UncategorizedDeadline For The Publication Of The UK CBD Novel...

Deadline For The Publication Of The UK CBD Novel Food List Slips – Once More


THE June deadline set by the UK Food Standards Agency for the publication of the Novel Food Public List of Validated CBD applications will pass today without any further updates.

This will be the third deadline the FSA has failed to achieve after initially informing the industry it expected to produce a comprehensive Validated list by the end of March, then in April, and later, by the end of June.

The ongoing uncertainty is proving to be a headache for many with major retail contracts still in limbo – as brands await approval from the UK’s food regulators. 

Yet Another Deadline Passes 

Following a call with The UK Food Standards Agency this morning BusinessCann received the following statement; 

The list will not be finalised by the end of the month as we don’t have all the information we need from some businesses to assess if their products can be added to the ‘on hold’ section of the CBD list.

“The public list will be updated when applicants have provided enough information in their applications to allow us to make a decision on validation. 

Businesses who have submitted applications by the 31 March deadline have been advised of the outstanding information required before their application can progress. It is up to the applicants to supply this information for their application to be validated and to allow the public list to be finalised.”

One industry leader told BusinessCann he is not surprised by developments: “There has been lots of false documentation provided for products that were not on the market prior to February 2020, and we’ve heard of companies whose validations have been withdrawn after submitting false data.”

At the end of May the FSA said of the 803 applications it had received with 250 of these had passed through to the Administration or Validation phases.

The first instalment of this Public List was published on April 19 and currently features four only bulk ingredient suppliers with some 43 products linked to these Validated applications.

One of these companies is Pureis Ultra Pure CBD. Acknowledging today’s developments it released the following statement: “The credibility of the UK FSA is undermined by not sticking to deadlines as it’s unfair to companies that provided all of the relevant details in time. It appears the CBD industry will continue to remain in limbo indefinitely.

What is the CBD Novel Food Process?

CBD is a thriving market set to be worth over £600m in the UK and increasingly popular in Europe, North America and the rest of the world.

In February, last year, the UK Food Standards Agency’s scientific advisors raised concerns about the safety of CBD.

It said it wanted all companies looking to sell CBD in the UK to submit applications through its Novel Food process by March 31, this year – which effectively meant applications had to be submitted by the middle of February to allow for the initial Administrative check.

The first stage of securing a Novel Food permit is the Administrative check, which is designed to ensure all the required documentation is in place, the second is Validation; ensuring it matches the requirements, including details on safety and toxicology studies and finally Authorisation.

When an application has passed through Validation, the applicant, and the products associated with that application, are published on the FSA’s Public List.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


  1. As a hemp farmer in Spain, a medical cannabis user for over 20 years, and founder of an information group Medical Cannabis Club UK over eight years ago, it is very clear to see the the International attempts to ‘hold back’ the evolution of CBD, and cannabis as a medicine. Banks refuse to process online payments, Governments still deny the medical benefits and continue to cite the dangers, Social Media organisations ban the advertising and promotion of it, even its use for animals has been restricted to a black market. All this while the patents list by the worlds biggest company GW Pharmaceuticals expands to cover nearly ALL ilnesses https://patents.justia.com/assignee/gw-pharma-limited This combined with lobbying by other Pharmaceutical companies is the reason.


Please enter your comment!
Please enter your name here

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth

Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a...

With Global Cannabis Cultivation Capacity Set To Outstrip Demand One Hundredfold – What Happened To The ‘Green’ Rush?

CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you